SLC12A2 and epilepsy: Two first-line ASMs like phenobarbital (PB) and valproate have shown little evidence that they reduce the subsequent incidence of epilepsy, a result which is tied to the regulation of the transmembrane Cl- gradient and the electroneutral ion transporters KCC2 and NKCC1.